Emerging World Pharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2009	FY 2007	FY 2006	FY 2005
Period Ending	Sep '10 Sep 30, 2010	Dec '09 Dec 31, 2009	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005
Revenue	-	-	0.01	-	-
Gross Profit	-	-	0.01	-	-
Selling, General & Admin	0.08	0.01	0.22	0	0
Operating Expenses	0.08	0.01	0.27	0	0
Operating Income	-0.08	-0.01	-0.27	-0	-0
Interest Expense	-0.14	-0.04	-0.03	-	-
EBT Excluding Unusual Items	-0.22	-0.06	-0.29	-0	-0
Other Unusual Items	-	-	-	-0.2	-
Pretax Income	-0.22	-0.06	-0.29	-0.2	-0
Net Income	-0.22	-0.06	-0.29	-0.2	-0
Net Income to Common	-0.22	-0.06	-0.29	-0.2	-0
Shares Outstanding (Basic)	88	3	3	5	0
Shares Outstanding (Diluted)	88	3	3	5	0
Shares Change (YoY)	3041.87%	1.49%	-46.96%	1000.00%	-
EPS (Basic)	-0.00	-0.02	-0.10	-0.04	-0.00
EPS (Diluted)	-0.00	-0.02	-0.10	-0.04	-0.00
Gross Margin	-	-	100.00%	-	-
Operating Margin	-	-	-3729.25%	-	-
Profit Margin	-	-	-4096.76%	-	-
EBITDA	-	-	-0.22	-	-
D&A For EBITDA	-	-	0.05	-	-
EBIT	-0.08	-0.01	-0.27	-0	-0
Advertising Expenses	-	-	0.06	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.